UPDATE : Thursday, August 13, 2020
Voluntary nullifications of drug license tripled in H1 by Lee Hye-seon 2019-06-26 14:25
Celltrion denies delay in local license application for HIV drug Temixys by Lee Hye-seon 2019-06-25 10:56
Anti-cancer Sutene could cause central nervous system abnormality in fetus by Lee Hye-seon 2019-06-24 11:35
LSK Global PS wins international recognition in clinical data management by Lee Hye-seon 2019-06-13 14:30
Daewoong joins fray to develop rheumatoid arthritis drug by Lee Hye-seon 2019-06-07 11:29
Regulator faces serious repercussions after Invossa debacle by Lee Hye-seon 2019-05-29 14:50
Invossa poses almost no safety threat: regulator by Lee Hye-seon 2019-05-28 16:02
Gore agrees to supply more artificial blood vessels for children by Lee Hye-seon 2019-05-24 12:53
‘Kolon’s extra data insufficient to explain Invossa mislabeling’ by Lee Hye-seon 2019-05-23 14:51
Regulator inspecting Kolon TissuGene in US this week by Lee Hye-seon 2019-05-20 14:22
Preventive use of statin lowers cardiovascular mortality by 44% in seniors by Lee Hye-seon 2019-05-15 11:54
YUHS to introduce ‘hospital medicine department' by Lee Hye-seon 2019-05-03 13:23
Yonsei Cancer Center to provide newest heavy ion therapy in 2022 by Lee Hye-seon 2019-05-02 15:43
When will regulator visit Kolon TissueGene for inspection? by Lee Hye-seon 2019-05-02 14:09
Medical device output up 11.8% in 2018 by Lee Hye-seon 2019-04-30 11:25
[Reporter’s Notebook]MFDS incapable of reviewing new drugs? by Lee Hye-seon 2019-04-29 16:12
Diarrhea drug Smecta banned for children under 2 by Lee Hye-seon 2019-04-24 15:42
OECD guideline OKs Korean-developed eye irritation test by Lee Hye-seon 2019-04-22 15:33
Kolon desperate to keep Invossa license amid suspicion of data fabrication by Lee Hye-seon 2019-04-18 11:16
Generic drug approvals doubled amid imminent scrap of consigned bioequivalence tests by Lee Hye-seon 2019-04-11 16:00
Back to Top